BRIEF published on 10/15/2025 at 07:35, 11 months 6 days ago INFICON to Release Q3 2025 Financial Results Web Conference INFICON Financial Update Investor Information Q3 2025 Results
PRESS RELEASE published on 10/15/2025 at 07:30, 11 months 6 days ago INFICON to Publish its Results for the Third Quarter of 2025 on Thursday, October 23, 2025 INFICON will publish its results for the Third Quarter of 2025 on Thursday, October 23, 2025. A web conference will follow at 09:30 a.m. CEST via Microsoft Teams Web Conference Microsoft Teams INFICON Results Third Quarter 2025
BRIEF published on 07/30/2025 at 07:05, 1 year 1 month ago INFICON's Strategic Growth Amid Challenging Trade Environment Sales Growth INFICON Semiconductor Asia Market Trade Environment
PRESS RELEASE published on 07/30/2025 at 07:00, 1 year 1 month ago INFICON on sustainable growth path in difficult environment INFICON Holding AG shows steady growth in second quarter 2025, with sales increasing 5.8%. Operating profit margin at 15.1%. Full year guidance adjusted to USD 660-690 million Sales Growth INFICON Holding AG Operating Profit Margin Second Quarter 2025 Full Year Guidance
BRIEF published on 07/17/2025 at 17:50, 1 year 2 months ago INFICON Schedules Release of Q2 and Half-Year 2025 Financial Results Web Conference Financial Presentation Investor Access INFICON Results Email Alerts
PRESS RELEASE published on 07/17/2025 at 17:45, 1 year 2 months ago INFICON to Publish its Second Quarter and Half-Year 2025 Results on Wednesday, July 30, 2025 INFICON Holding AG to publish Q2 and Half-Year 2025 results on July 30, 2025. Web Conference scheduled for investors. Communication calendar and e-mail alerts available Investors Web Conference INFICON Holding AG Q2 Results Half-year 2025
BRIEF published on 04/24/2025 at 07:05, 1 year 4 months ago INFICON Reports Solid First Quarter 2025 with Positive Outlook Profitability Sales Growth Market Performance Q1 2025 Results Guidance 2025
PRESS RELEASE published on 04/24/2025 at 07:00, 1 year 4 months ago INFICON: Solid first quarter 2025 and generally positive outlook; guidance confirmed INFICON Holding AG reports a solid first quarter 2025 with sales growth and improved profitability. The company confirms its guidance for the year 2025 amidst a dynamic macro environment Sales Growth Operating Income INFICON Guidance First Quarter 2025
BRIEF published on 04/11/2025 at 17:45, 1 year 5 months ago INFICON to Release Q1 2025 Results on April 24 Investor Relations Financial Calendar Web Conference INFICON Q1 Results 2025
PRESS RELEASE published on 04/11/2025 at 17:40, 1 year 5 months ago INFICON to Publish its Results for the First Quarter of 2025 on Thursday, April 24, 2025 INFICON will publish its first quarter 2025 results on April 24, 2025, with a web conference via Microsoft Teams at 09:30 a.m. CEST. Information available on www.inficon.com Investors Web Conference Microsoft Teams First Quarter Results INFICON
Published on 09/21/2026 at 15:45, 2 hours 6 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 3 hours 31 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 3 hours 46 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 3 hours 51 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 4 hours 6 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 17:45, 6 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 6 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 51 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 16:19, 1 hour 32 minutes ago clearvise signs new Power Purchase Agreements on favorable terms
Published on 09/21/2026 at 07:00, 10 hours 51 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 23 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
